Back to Search Start Over

Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A Mayo Clinic Cohort Study

Authors :
Arushi Khurana
Raphael Mwangi
Rebecca L. King
Thomas M. Habermann
Stephen M. Ansell
James R. Cerhan
Grzegorz S. Nowakowski
Thomas E. Witzig
Matthew J. Maurer
Source :
Blood. 140:6666-6667
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........a9702247ea30e68cad9382d145a38de7
Full Text :
https://doi.org/10.1182/blood-2022-169575